Clinical Trials Directory

Trials / Completed

CompletedNCT06184282

Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer

Assessment of Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer: Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
October 6 University · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This study aims to assess topical MEBO application on pain relief and wound healing.

Detailed description

One of the conditions that affect the mouth frequently is a traumatic ulcer. Between 3 and 24 % of the population are affected, which is a significant prevalence. It is symptomatic to treat traumatized ulcers. Oral wound healing is a dynamic process and complicated phenomenon involving secondary concerns, a succession of overlapping stages of rebuilding cell and tissue structure. Inflammation, granulation tissue creation, matrix formation, re-epithelialization, and tissue remodeling are some of the cellular and physiological activities that occur during wound healing. Oral wound healing is a dynamic process and complex phenomenon involving secondary issues, series overlapping stages of restoring tissue and cellular structures. Since 1995, the Moist Exposed Burn Ointment (MEBO), a Chinese burn ointment, has had a recognized US patent. Beta-sitosterol, Phellodendron amurense, Scutellaria baicalensis, Coptis chinensis, Pheretima aspergillum, Beeswax, and sesame oil are all natural ingredients found in MEBO, a pure herbal extract.

Conditions

Interventions

TypeNameDescription
DRUGMEBOMEBO (Julphar®, Ras Al Khaimah, United Arab Emirates) was applied using sterile plastic brush daily and the patients were recalled at 2, 5 and 10 days for evaluating the healing of the ulcer.
DRUGLidocaineLidocaine gel was applied using sterile plastic brush daily and the patients were recalled at 2, 5 and 10 days for evaluating the healing of the ulcer.

Timeline

Start date
2023-07-01
Primary completion
2023-08-01
Completion
2023-08-01
First posted
2023-12-28
Last updated
2024-01-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06184282. Inclusion in this directory is not an endorsement.